How to deal with the occurrence of rare drug-induced adverse events: the example of sprue-like enteropathy induced by olmesartan medoxomil and other angiotensin-receptor blockers
Main Authors: | Michel Burnier, Sverre E. Kjeldsen, Krzysztof Narkiewicz, Suzanne Oparil |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-03-01
|
Series: | Blood Pressure |
Online Access: | http://dx.doi.org/10.1080/08037051.2020.1726101 |
Similar Items
-
Olmesartan-Induced Sprue Like Enteropathy
by: Liliana Carneiro, et al.
Published: (2016-03-01) -
Sprue-like enteropathy due to olmesartan
by: Cándido Muñoz-Muñoz, et al.
Published: (2015-10-01) -
Sprue-Like Enteropathy Associated with Olmesartan: An Unrecognized Emerging Drug-Induced Enteropathy?
by: Luís Carvalho Lourenço, et al.
Published: (2016-11-01) -
Severe olmesartan-induced sprue-like enteropathy with good corticosteroid treatment response
by: R. Alonso-Beato, et al.
Published: (2020-04-01) -
Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block
by: Isabel A. Hujoel, et al.
Published: (2016-03-01)